Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Cswc Uptrend Accelerates On Buyback 20260403 1 What Is The Growth Rate Of Peraso Prso Stock Price At 1.01 Up 1.00 20260410 Is New Gbr Stock Good For Passive Investors Price At 0.77 Down 2.41 20260410 How Expensive Is Mesa Laboratories Mlab Stock Now Price At 95.05 Up 2.39 20260410 Bzfd Stock Analysis Buzzfeed Inc. Dips 1.16 To 0.59 Digital Media Sector Check 20260403 Is Kratos Ktos Stock Risky Now Price At 72.43 Up 2.98 20260328 Apge Stock Analysis Apogee Therapeutics Inc Holds 85.66 Level Post 1.77 Pct Biotech Gain 20260401 1 Is Strive ASST stock losing direction Flat 20260420 Pagaya PGY Stock Momentum Trade 254 20260420 Is SharonAI Holdings SHAZ stock worth a closer look Breakdown Watch 20260420 POWI Power Integrations Q4 2025 earnings exceed forecasts shares rise 286 percent on upbeat investor sentiment BLUWW BlueWater Wt quarterly earnings details are not yet public as investors await official corporate disclosures NDLS Noodles and tops Q4 2025 loss estimates shares rise 754 percent on favorable investor reaction How does market volatility impact Peoples PFIS stock 018 20260420 EXC Exelon Corporation reports Q4 2025 earnings beat and 53 percent YoY revenue growth shares dip slightly Is Ero Copper ERO stock relatively secure Ero Copper reports narrow 09 EPS miss against consensus Is Nixxy NIXX stock stabilizing Q3 2023 EPS Beats Forecasts Blk Debt DSU Stock What Drives Price RangeBound 20260420 East West EWBC Stock IPO Activity Market Focus 20260420 GECC Great Elm posts 115 percent Q4 2025 earnings miss shares hold steady in regular trading Vanguard Information Technology ETF VGT Is the Ongoing Nasdaq Correction a Prime LongTerm Entry Point IBO Impact BioMedical highlights promising preclinical trial progress in its latest quarterly earnings release Occidental Petroleum OXY Durable Competitive Moats Berkshire Backing Support Continued MarketBeating Performance SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss 2024 US Tax Day Regulatory Updates and Filing Guidance